m+Medelevator.RU
← Поиск публикаций
Journal of oral microbiology · 2025

Rapid Griess assay (RGA): a chairside test for ex vivo semi-quantitative oral nitrite measurement and in vitro assessment of nitrite production by oral bacteria.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mavropoulos Simeon K B, Zaiton Rabi, Basic Amina, Dahlén Gunnar

Аннотация

BACKGROUND: Nitrite (NO2 -) is produced through enzymatic reduction of dietary nitrate (NO3 -) by oral bacteria: a process contributing to cardiovascular - and possibly oral - health. NO2 - quantitation in biological samples is a complex exercise, and available methods are not well-adapted for chairside use. Therefore, we aimed to develop and evaluate a semi-quantitative chairside test for NO2 - in oral samples. We also evaluated NO2 - generation in several bacterial species in vitro.

MATERIALS AND METHODS: From 12 healthy individuals, tongue, saliva and plaque samples were collected and evaluated chairside across 4 weeks, using the rapid Griess assay (RGA). The RGA was further used to test bacterial species for NO2 - production.

RESULTS: In saliva, plaque and tongue samples, low, variable and high NO2 - levels, respectively, were found. Tongue samples were the most stable over time. High and medium NO2 - production capacities were shown by Actinomyces spp. (including Schaalia odontolytica), Veillonella parvula, and Rothia spp. RGA results were reproducible.

CONCLUSION: The RGA provided stable and reliable results for chairside NO2 - semi-quantitation, and revealed elevated and stable NO2 - levels on the tongue. In vitro, bacterial NO2 - production was consistent with the available literature, but uncertainty remains regarding Neisseria spp. Our results showed promise for clinical and research applications of the RGA.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты